Search - tctmd.com

Displaying 161 - 180 of 260

Sort: Relevancy | Date

Presentation EuroPCR 2016

Sealing Moderate Coronary Saphenous Vein Graft Lesions with Drug-Eluting Stents as a New Approach to Reducing Cardiac Events The VELETI II Randomized Trial

Presenter: Josep Rod?s-Cabau

May 19, 2016

News Conference News EuroPCR 2016

Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events

Shelley Wood

May 18, 2016

News Conference News AHA 2015

DAPT Score Provides ‘Personalized Medicine’ Tool for Determining Whether to Extend Therapy Beyond 1 Year

Yael L. Maxwell

November 09, 2015

News Features

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Todd Neale

November 08, 2015

Presentation TCT 2015

New Approaches for Diffuse Disease: DEB, BRS, and Beyond

Presenter: Jeffrey W. Moses, Erick Schampaert, Giuseppe Tarantini

October 14, 2015

Presentation TCT 2015

SVG Intervention: Is Distal Protection Still Needed? And Should We Always Do the Native Vessel Instead?

Presenter: Jeffrey W. Moses, Erick Schampaert, Dimitri Karmpaliotis

October 14, 2015

Presentation TCT 2015

Debate: Should Atheroablation Be Used More Often? Yes, Atheroablation Is Underutilized!

Presenter: Jeffrey W. Moses, Erick Schampaert, Nabil Dib

October 14, 2015

Presentation TCT 2015

Debate: Should Atheroablation Be Used More Often? No, the Present Evidence Says It Should Be Used Sparingly!

Presenter: Jeffrey W. Moses, Erick Schampaert, Gert Richardt

October 14, 2015

Presentation TCT 2015

Atheroablation: Current Technologies and Techniques

Presenter: Jeffrey W. Moses, Erick Schampaert, Mohamed Abdel-Wahab

October 14, 2015

Presentation TCT 2015

CTO in Patients With Left Main and Multivessel Disease: Why and When to Treat

Presenter: Jeffrey W. Moses, Erick Schampaert, Barry D. Rutherford

October 14, 2015

Presentation TCT 2015

Sorting Through Revascularization Choices in Left Main and Multivessel Disease: A Practical Approach

Presenter: Jeffrey W. Moses, Erick Schampaert

October 14, 2015

Presentation TCT 2015

Just How Effective Is Hypothermia in Cardiac Arrest?

Presenter: Tanveer Rab, Holger Thiele, Michel R. Le May

October 14, 2015

Presentation TCT 2015

The Role (and Timing) of Complete Revascularization in AMI and Cardiogenic Shock

Presenter: Tanveer Rab, Holger Thiele

October 14, 2015

Presentation TCT 2015

Escalation Therapies and RV Dysfunction: New Opportunities

Presenter: Tanveer Rab, Holger Thiele, Navin K. Kapur

October 14, 2015

Presentation TCT 2015

Debate: What Support Device Should Most Frequently Be Used in Cardiogenic Shock? ECMO for True Shock!

Presenter: Tanveer Rab, Holger Thiele, Aly El Banayosy

October 14, 2015

Presentation TCT 2015

Debate: What Support Device Should Most Frequently Be Used in Cardiogenic Shock? IABP Is Still Frontline!

Presenter: Tanveer Rab, Holger Thiele, Sunil V. Rao

October 14, 2015

Presentation TCT 2015

What Support Device Should Most Frequently Be Used in Cardiogenic Shock? Impella for Most!

Presenter: Tanveer Rab, Holger Thiele, Jose P.S. Henriques

October 14, 2015

Presentation TCT 2015

The Spectrum of Hemodynamic Support Options for Shock

Presenter: Tanveer Rab, Holger Thiele, Vladimir Dzavik

October 14, 2015

Presentation TCT 2015

The Role of the Life Vest, ICDs, and BiV Pacing in Patients With LV Dysfunction

Presenter: Robert O. Bonow, Ajay J. Kirtane, William T. Abraham

October 14, 2015

Presentation TCT 2015

Temporary Cardiac Support During High-Risk PCI: HeartMate PHP and the SHIELD I Study

Presenter: Robert O. Bonow, Ajay J. Kirtane, David E. Kandzari

October 14, 2015

Advertisement

Sealing Moderate Coronary Saphenous Vein Graft Lesions with Drug-Eluting Stents as a New Approach to Reducing Cardiac Events The VELETI II Randomized Trial

Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events

DAPT Score Provides ‘Personalized Medicine’ Tool for Determining Whether to Extend Therapy Beyond 1 Year

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

New Approaches for Diffuse Disease: DEB, BRS, and Beyond

SVG Intervention: Is Distal Protection Still Needed? And Should We Always Do the Native Vessel Instead?

Debate: Should Atheroablation Be Used More Often? Yes, Atheroablation Is Underutilized!

Debate: Should Atheroablation Be Used More Often? No, the Present Evidence Says It Should Be Used Sparingly!

Atheroablation: Current Technologies and Techniques

CTO in Patients With Left Main and Multivessel Disease: Why and When to Treat

Sorting Through Revascularization Choices in Left Main and Multivessel Disease: A Practical Approach

Just How Effective Is Hypothermia in Cardiac Arrest?

The Role (and Timing) of Complete Revascularization in AMI and Cardiogenic Shock

Escalation Therapies and RV Dysfunction: New Opportunities

Debate: What Support Device Should Most Frequently Be Used in Cardiogenic Shock? ECMO for True Shock!

Debate: What Support Device Should Most Frequently Be Used in Cardiogenic Shock? IABP Is Still Frontline!

What Support Device Should Most Frequently Be Used in Cardiogenic Shock? Impella for Most!

The Spectrum of Hemodynamic Support Options for Shock

The Role of the Life Vest, ICDs, and BiV Pacing in Patients With LV Dysfunction

Temporary Cardiac Support During High-Risk PCI: HeartMate PHP and the SHIELD I Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content